- Home
- IMNM vs HBANP Comparison
IMNM vs HBANP Comparison
Compare IMNM & HBANP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMNM
- HBANP
- Stock Information
- Founded
- IMNM 2006
- HBANP N/A
- Country
- IMNM United States
- HBANP United States
- Employees
- IMNM N/A
- HBANP 20092
- Industry
- IMNM Medicinal Chemicals and Botanical Products
- HBANP Major Banks
- Sector
- IMNM Health Care
- HBANP Finance
- Exchange
- IMNM Nasdaq
- HBANP Nasdaq
- Market Cap
- IMNM 748.3M
- HBANP N/A
- IPO Year
- IMNM 2020
- HBANP N/A
- Fundamental
- Price
- IMNM $8.40
- HBANP $17.62
- Analyst Decision
- IMNM Strong Buy
- HBANP
- Analyst Count
- IMNM 5
- HBANP 0
- Target Price
- IMNM $26.40
- HBANP N/A
- AVG Volume (30 Days)
- IMNM 1.1M
- HBANP N/A
- Earning Date
- IMNM 08-11-2025
- HBANP N/A
- Dividend Yield
- IMNM N/A
- HBANP N/A
- EPS Growth
- IMNM N/A
- HBANP N/A
- EPS
- IMNM N/A
- HBANP N/A
- Revenue
- IMNM $10,938,000.00
- HBANP N/A
- Revenue This Year
- IMNM N/A
- HBANP N/A
- Revenue Next Year
- IMNM $259.34
- HBANP N/A
- P/E Ratio
- IMNM N/A
- HBANP N/A
- Revenue Growth
- IMNM N/A
- HBANP N/A
- 52 Week Low
- IMNM $5.15
- HBANP N/A
- 52 Week High
- IMNM $16.81
- HBANP N/A
- Technical
- Relative Strength Index (RSI)
- IMNM 44.32
- HBANP 53.81
- Support Level
- IMNM $8.40
- HBANP $17.51
- Resistance Level
- IMNM $9.27
- HBANP $17.86
- Average True Range (ATR)
- IMNM 0.46
- HBANP 0.23
- MACD
- IMNM -0.06
- HBANP 0.02
- Stochastic Oscillator
- IMNM 7.06
- HBANP 56.45
About IMNM Immunome Inc.
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.
About HBANP Huntington Bancshares
Huntington is a regional US bank with around $200 billion in assets (as of 2024) and has a large presence, particularly in the Midwestern market. It offers a full suite of consumer deposit and lending services, along with commercial services focused on payments, investment management, capital markets, equipment financing, treasury management, and other common banking services.